GlybatomaqTM312317b: Novel Series of Quantum Thinking Ligands targeted to the Glioma target | Dodax.com
Ioannis Grigoriadis - QUANTUM CHEMIST DRUG DESIGNER CELL AND GENE THERAPY ENGINEER - BIOGENEA PHARMACEUTICALS LTD | LinkedIn
PDF) Chern-Simons Topology Geometrics for the generation of the RoccustyrnaTM molecule, a ligand targeting COVID-19-SARS-COV-2 SPIKE D614G binding sites
Ioannis Grigoriadis (biogenea) - Προφίλ | Pinterest
ΙΑΤΩΡ "ο γιατρός,θεραπευτής" Biogenea Pharmaceuticals, η πρώτη Ελληνική εταιρεία παραγωγής Φαρμάκων προηγμένων θεραπειών (Φ.Π.Θ)
Chemistry Congress 2019 | Chemistry Conferences | Rome | Italy
Organizing Committee | Nanotechnology Congress 2019 | Nanotechnology Meetings | World Nanotechnology Congress | Nanotechnology Conferences 2019 | Nanotechnology Conference 2019 | Nanotechnology Conferences Dubai 2019 | World Nanotechnology Conferences ...
Ioannis Grigoriadis - QUANTUM CHEMIST DRUG DESIGNER CELL AND GENE THERAPY ENGINEER - BIOGENEA PHARMACEUTICALS LTD | LinkedIn
Organizing Committee | Nanotechnology Congress 2019 | Nanotechnology Meetings | World Nanotechnology Congress | Nanotechnology Conferences 2019 | Nanotechnology Conference 2019 | Nanotechnology Conferences Dubai 2019 | World Nanotechnology Conferences ...
GlybatomaqTM312317b: Novel Series of Quantum Thinking Ligands targeted to the Glioma target, 978-613-8-91609-3, 6138916093 ,9786138916093 by ioannis Grigoriadis
Ioannis Grigoriadis | Scientific Director | Medicinal Chemistry 2018 | Meetings International
PDF) A Novel Combined Methodology for Isolation and Detection of Circulating Tumor Cells based on Flow Cytometry and Cellular Filtration Technologies
Ioannis Grigoriadis - QUANTUM CHEMIST DRUG DESIGNER CELL AND GENE THERAPY ENGINEER - BIOGENEA PHARMACEUTICALS LTD | LinkedIn
Απάτη Κορονοϊού / COVID-19 Hoax] Ο Ιωάννης Γρηγοριάδης, Φαρμακοποιός, Μοριακός Σχεδιαστής Φαρμάκων, Αποκαλύπτει Ότι Έχει Σχεδιάσει Φάρμακο Που Κάνει Καλά Τον Κορονοϊό, Αλλά…! (Video) | DER KAMERAD
ΙΑΤΩΡ "ο γιατρός,θεραπευτής" Biogenea Pharmaceuticals, η πρώτη Ελληνική εταιρεία παραγωγής Φαρμάκων προηγμένων θεραπειών (Φ.Π.Θ)
2017 « H.bioinfo
Association of TNFα, TNFR1, and TNFR2 Polymorphisms With Sperm Concentration and Motility - Lazaros - 2012 - Journal of Andrology - Wiley Online Library
Pharmacological preconditioning for short-term ex vivo expansion of human umbilical cord blood hematopoietic stem cells by filgrastim. - Abstract - Europe PMC
PDF) Quantum Deep Learning Functional Similarities on Remdesivir, Drug Synergies to Treat COVID-19 in Practice.
Ioannis Grigoriadis - QUANTUM CHEMIST DRUG DESIGNER CELL AND GENE THERAPY ENGINEER - BIOGENEA PHARMACEUTICALS LTD | LinkedIn